Showing 141 - 160 results of 125,354 for search '(((( ((b large) OR (a large)) decrease ) OR ( i larvae decrease ))) OR ( 1 levels increased ))', query time: 1.90s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144

    Expression levels of <i>C</i>. <i>albicans</i> MDR1 gene determined by real-time PCR. by Bruno Maras (152370)

    Published 2021
    “…<p>The expression level of the MDR1 gene in the wild-type (CO23), resistant (CO23RFK, CO23RFLC and CO23RR) strains and Clinical Isolates (CI1 and CI2) are represented as n-fold increase or decrease relative to the level of the control strain (CO23). …”
  5. 145
  6. 146

    Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx by Chaofeng Zhang (845343)

    Published 2024
    “…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”
  7. 147

    Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

    Published 2024
    “…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”
  8. 148
  9. 149
  10. 150
  11. 151
  12. 152

    Fig 3 - by Olaf Nickel (9524791)

    Published 2022
    Subjects:
  13. 153

    Fig 6 - by Olaf Nickel (9524791)

    Published 2022
    Subjects:
  14. 154

    Image_1_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

    Published 2023
    “…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”
  15. 155
  16. 156

    Metabolites with increasing levels during the development. by Martin Sládek (130663)

    Published 2025
    “…<p>Temporal profiles of polar metabolites and lipids with SCN levels significantly increasing from E19 to P28. Rhythmicity was determined by eJTK; full or dashed lines depict the profiles that either did or did not pass the significance threshold (FDR-adjusted <i>P</i> < 0.05), respectively.…”
  17. 157

    Table_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx by Boram Lee (549836)

    Published 2021
    “…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …”
  18. 158
  19. 159
  20. 160

    (a) Measuring device; (b) Measuring method. by Chenhao Li (822769)

    Published 2025
    “…Although increasing SHMP content improved the early strength, it led to a decrease in later strength, with the maximum late strength observed at 2% SHMP. …”